Back
OrganiGram Holdings Vs. Aurinia Pharmaceuticals Industry Stock Comparison
Sell
28
OGI
OrganiGram Holdings
Last Price:
1.76
Seasonality Move:
-5.77%
Sell
48
AUPH
Aurinia Pharmaceuticals
Last Price:
5.03
Seasonality Move:
3.33%
Sell
28
OrganiGram Holdings (OGI)
is a Sell
Is OrganiGram Holdings a Buy, Sell or Hold?
- The current OrganiGram Holdings [OGI] share price is $1.76. The Score for OGI is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- OGI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Aurinia Pharmaceuticals (AUPH)
is a Sell
Is Aurinia Pharmaceuticals a Buy, Sell or Hold?
- The current Aurinia Pharmaceuticals [AUPH] share price is $5.02. The Score for AUPH is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- AUPH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
OGI Stock Price Chart
What is OrganiGram Holdings's stock price today?
-
The OrganiGram Holdings share price today is $1.76
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OGI is experiencing selling pressure, which indicates risk of future bearish movement.
AUPH Stock Price Chart
What is Aurinia Pharmaceuticals's stock price today?
-
The Aurinia Pharmaceuticals share price today is $5.02
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AUPH is experiencing selling pressure, which indicates risk of future bearish movement.
OGI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.07 | Sell |
| Relative Strength Index (14 RSI): | 40.75 | Sell |
| Chaikin Money Flow: | -390694 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.8 - 2.02) | Sell |
| Bollinger Bands (100): | (1.57 - 2.19) | Sell |
AUPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 45.08 | Sell |
| Chaikin Money Flow: | -1187685 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.95 - 5.15) | Sell |
| Bollinger Bands (100): | (4.92 - 8.06) | Sell |
OGI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.83 | Sell |
| 20-day SMA: | 1.87 | Sell |
| 50-day SMA: | 2.04 | Sell |
| 200-day SMA: | 1.61 | Buy |
| 8-day EMA: | 1.82 | Sell |
| 20-day EMA: | 1.89 | Sell |
| 50-day EMA: | 1.95 | Sell |
| 200-day EMA: | 1.9 | Sell |
AUPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.14 | Sell |
| 20-day SMA: | 5.04 | Sell |
| 50-day SMA: | 5.14 | Sell |
| 200-day SMA: | 7.58 | Sell |
| 8-day EMA: | 5.1 | Sell |
| 20-day EMA: | 5.09 | Sell |
| 50-day EMA: | 5.41 | Sell |
| 200-day EMA: | 7.15 | Sell |
OrganiGram Holdings Earnings Growth & OGI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.83 per share, and an increase next year of $0.17 per share.
Aurinia Pharmaceuticals Earnings Growth & AUPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.65 per share, and an increase next year of $0.35 per share.
OrganiGram Holdings Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Aurinia Pharmaceuticals Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||